Benefits of using a microencapsulated vitamin D delivery system in women
                        with polycystic ovary syndrome

Yanachkova, Vesselina; Staynova, Radiana; Stoev, Svetoslav; Naseva, Emilia

doi:10.1136/ejhpharm-2021-002967

Cited by 3 publications

(3 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a cross-sectional study conducted in Bulgaria, Staynova and Lambreva assessed elderly patients' attitudes towards prescribed medications and satisfaction with the provided pharmaceutical care services. The results from this study showed that the geriatric patients have a positive attitude towards the provided pharmaceutical care services [17]. In carrying out their professional duties, however, pharmacists encounter barriers that prevent the use of pharmaceutical care, especially for vulnerable groups such as children.…”

Section: Resultsmentioning

confidence: 77%

Bulgarian Pharmacists’ Attitudes and Barriers Towards Pharmaceutical Care Provision for Increasing Immunity in Children

Mihaylova¹

2023

FARMACIA

View full text Add to dashboard Cite

A cross-sectional, anonymous questionnaire-based study was performed among 158 participants to assess the pharmacists' attitudes and barriers towards providing pharmaceutical care for increasing immunity in children in Bulgarian community pharmacies. 93.7% of the respondents consider pharmaceutical care to be main priority and responsibility of the pharmacist when it comes to children. 97.5% agreed/strongly agreed with the statement that providing pharmaceutical care will improve health of children and the awareness of their parents. 84.8% of the respondents reported that they agreed/strongly agreed that preventing, detecting and solving problems related to children's health and drug therapy is an important responsibility of the pharmacist. Main barriers to the effective provision of pharmaceutical care for children according to 72.2% of pharmacists are the lack of additional training and lack of payment for the service in pharmacies. They are followed by the lack of time as the main barrier (70.8%). The lack of a separate place for consultation is an obstacle for 62% of the respondents and for 65.8%, a significant obstacle for effective consultation is the lack of access to medical documentation or electronic file of the child. Bulgarian pharmacists generally have positive attitudes towards the provision of pharmaceutical care for children and are available to advise their parents on the management of children's immunity. Despite the existence of some barriers, pharmacists demonstrate a high degree of responsibility in providing care and consulting on immuno-stimulation in children and are willing to increase knowledge and skills in this field through postgraduate training and specialization. RezumatPentru a evalua atitudinea și limitele farmaciștilor privind furnizarea de servicii farmaceutice destinate creșterii imunității copiilor, în farmaciile comunitare din Bulgaria, a fost realizat un studiu transversal, anonim, bazat pe chestionar, în rândul a 158 de participanți. 93,7% dintre respondenți consideră că îngrijirea farmaceutică este principala prioritate și responsabilitate a farmacistului atunci când vine vorba de copii. 97,5% au fost de acord cu furnizarea serviciilor de îngrijire farmaceutică pentru a îmbunătăți sănătatea copiilor și a crește gradul de conștientizare al părinților lor. 84,8% dintre respondenți au raportat că sunt de acord că prevenirea, detectarea și rezolvarea problemelor legate de sănătatea copiilor precum și terapia medicamentoasă reprezintă responsabilități importante ale farmaciștilor. Principalele bariere în calea asigurării efective a îngrijirii farmaceutice pentru copii, conform cu 72,2% dintre farmaciști, sunt lipsa pregătirii suplimentare și lipsa remunerației pentru serviciul respectiv, acestea sunt urmate de lipsa timpului (70,8%). Absența unui loc separat pentru consultație reprezintă un obstacol pentru 62% dintre respondenți. Pentru 65,8%, un obstacol semnificativ pentru o consultare eficientă a este reprezentat de lipsa accesului la documentația medicală sau la dosarul ele...

show abstract

Section: Resultsmentioning

confidence: 77%

Bulgarian Pharmacists’ Attitudes and Barriers Towards Pharmaceutical Care Provision for Increasing Immunity in Children

Mihaylova¹

2023

FARMACIA

View full text Add to dashboard Cite

show abstract

“…Furthermore, before commercializing microencapsulated vitamin products, particularly fat-soluble vitamins, their toxicity and safety in the human body should be evaluated. 127,128 Nicotine is an addictive substance. Conventionally, it is taken in by smoking tobacco products.…”

Section: Microencapsulation Of Smallmentioning

confidence: 99%

“…However, more research work is needed regarding impacts of different vitamin types and their microcapsule size on their bioaccessibility and biocompatibility in vitro/in vivo. Furthermore, before commercializing microencapsulated vitamin products, particularly fat-soluble vitamins, their toxicity and safety in the human body should be evaluated. , …”

Section: Applicationsmentioning

confidence: 99%

Microencapsulation for Pharmaceutical Applications: A Review

Yan,

Kim

2024

ACS Appl. Bio Mater.

View full text Add to dashboard Cite

In order to improve bioavailability, stability, control release, and target delivery of active pharmaceutical ingredients (APIs), as well as to mask their bitter taste, to increase their efficacy, and to minimize their side effects, a variety of microencapsulation (including nanoencapsulation, particle size <100 nm) technologies have been widely used in the pharmaceutical industry. Commonly used microencapsulation technologies are emulsion, coacervation, extrusion, spray drying, freeze-drying, molecular inclusion, microbubbles and microsponge, fluidized bed coating, supercritical fluid encapsulation, electro spinning/spray, and polymerization. In this review, APIs are categorized by their molecular complexity: small APIs (compounds with low molecular weight, like Aspirin, Ibuprofen, and Cannabidiol), medium APIs (compounds with medium molecular weight like insulin, peptides, and nucleic acids), and living microorganisms (such as probiotics, bacteria, and bacteriophages). This article provides an overview of these microencapsulation technologies including their processes, matrix, and their recent applications in microencapsulation of APIs. Furthermore, the advantages and disadvantages of these common microencapsulation technologies in terms of improving the efficacy of APIs for pharmaceutical treatments are comprehensively analyzed. The objective is to summarize the most recent progresses on microencapsulation of APIs for enhancing their bioavailability, control release, target delivery, masking their bitter taste and stability, and thus increasing their efficacy and minimizing their side effects. At the end, future perspectives on microencapsulation for pharmaceutical applications are highlighted.

show abstract

Hormonal, genetic, epigenetic and environmental aspects of polycystic ovarian syndrome

et al. 2022

View full text Add to dashboard Cite

Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome

Cited by 3 publications

References 25 publications

Bulgarian Pharmacists’ Attitudes and Barriers Towards Pharmaceutical Care Provision for Increasing Immunity in Children

Bulgarian Pharmacists’ Attitudes and Barriers Towards Pharmaceutical Care Provision for Increasing Immunity in Children

Microencapsulation for Pharmaceutical Applications: A Review

Hormonal, genetic, epigenetic and environmental aspects of polycystic ovarian syndrome

Contact Info

Product

Resources

About